mdlinx mdlinx

Oncology - Alternative Therapies News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest Full Text Articles (26) Focus on Renal
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Anti-tumor effects of various furocoumarins isolated from the roots, seeds and fruits of Angelica and Cnidium species under ultraviolet A irradiation Journal of Natural Medicines, May 22, 2013    Clinical Article

2 Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese over 50 years of age: a randomized clinical trial Cancer Prevention Research, May 20, 2013    Clinical Article

3 Sensitivity of assays for the detection of HPA-1a antibodies: results of an international workshop demonstrating the impact of cation chelation from integrin αIIbβ3 on three widely used assays Vox Sanguinis, May 14, 2013    Clinical Article

4 Caffeic acid-conjugated chitosan derivatives and their anti-tumor activity Full Text Archives of Pharmacal Research, May 13, 2013    Review Article

5 The immunomodulatory and anticancer properties of propolis Clinical Reviews in Allergy and Immunology, May 9, 2013    Review Article

6 Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series Full Text Evidence-based Complementary and Alternative Medicine , May 8, 2013    Clinical Article

7 Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-kB signaling pathway with distinct mechanisms Acta Pharmacologica Sinica, May 7, 2013    Clinical Article

8 Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs Journal of Ethnopharmacology , May 6, 2013    Review Article

9 Advanced Targeted, Cell and Gene-Therapy Approaches for Pediatric Hematological Malignancies: Results and Future Perspectives Frontiers in Oncology, May 3, 2013    Clinical Article

10 Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP pathways Clinical Cancer Research, April 30, 2013    Clinical Article

11 Antihyperglycemic Drug Gymnema sylvestre Also Shows Anticancer Potentials in Human Melanoma A375 Cells via Reactive Oxygen Species Generation and Mitochondria-Dependent Caspase Pathway Integrative Cancer Therapies , April 30, 2013    Clinical Article

12 Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine Cancer Immunology, Immunotherapy, April 29, 2013    Review Article

13 CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes Cancer Immunology, Immunotherapy, April 29, 2013    Clinical Article

14 Extracts from Epilobium sp. herbs induce apoptosis in human hormone-dependent prostate cancer cells by activating the mitochondrial pathway Journal of Pharmacy and Pharmacology, April 29, 2013    Clinical Article

15 Phyllanthus Suppresses Prostate Cancer Cell, PC-3, Proliferation and Induces Apoptosis through Multiple Signalling Pathways (MAPKs, PI3K/Akt, NFB, and Hypoxia) Full Text Evidence-based Complementary and Alternative Medicine , April 26, 2013    Clinical Article

16 Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles Cancer Immunology, Immunotherapy, April 26, 2013    Clinical Article

17 Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects Cancer Immunology, Immunotherapy, April 26, 2013    Clinical Article

18 Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment Full Text OncoTargets and Therapy, April 26, 2013    Clinical Article

19 Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells Cancer Immunology, Immunotherapy, April 25, 2013    Clinical Article

20 Decursin Exerts Anti-cancer Activity in MDA-MB-231 Breast Cancer Cells Via Inhibition of the Pin1 Activity and Enhancement of the Pin1/p53 Association Phytotherapy Research, April 22, 2013    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close